709 filings
8-K
SNOA
Sonoma Pharmaceuticals Inc.
9 Apr 24
Regulation FD Disclosure
7:30am
8-K
SNOA
Sonoma Pharmaceuticals Inc.
2 Apr 24
Sonoma Pharmaceuticals, Inc. Investor Presentation April 2024
7:30am
8-K
SNOA
Sonoma Pharmaceuticals Inc.
22 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
SNOA
Sonoma Pharmaceuticals Inc.
8 Mar 24
Entry into a Material Definitive Agreement
4:29pm
424B3
SNOA
Sonoma Pharmaceuticals Inc.
8 Mar 24
Prospectus supplement
4:27pm
8-K
j6eiky1nv7x4o3un8
10 Jan 24
Sonoma Pharmaceuticals, Inc. Investor Presentation January 2024
7:30am
8-K
4q4tcguohi0dx3
9 Jan 24
Entry into a Material Definitive Agreement
4:47pm
4
ih0h7lcud0r6fwt xk1w
29 Dec 23
Sonoma Pharmaceuticals / Amy Moss Trombly ownership change
5:26pm
4
zaqchbxs5sxnwh1 54c
29 Dec 23
Sonoma Pharmaceuticals / Bruce Thornton ownership change
5:25pm
4
8c2ne1gb1tb47mw
29 Dec 23
Sonoma Pharmaceuticals / Poggetto John Dal ownership change
5:25pm
4
j1g2j4yk vhvv
29 Dec 23
Sonoma Pharmaceuticals / JEROME J DVONCH ownership change
5:24pm
8-K
13v86
29 Dec 23
Departure of Directors or Certain Officers
5:23pm
8-K
gjrgp0oi
15 Dec 23
Entry into a Material Definitive Agreement
6:14pm
424B3
olszlzm6sp3odk
15 Dec 23
Prospectus supplement
5:30pm
424B5
o3ocfl jgcpzb5tpkx
22 Nov 23
Prospectus supplement for primary offering
4:30pm
EFFECT
5v625h2 pk
21 Nov 23
Notice of effectiveness
12:15am
CORRESP
1mon1r6
17 Nov 23
Correspondence with SEC
12:00am
UPLOAD
1tagz1d8i4kzt
7 Nov 23
Letter from SEC
12:00am